HomeOrthofix International N.V.

Orthofix International N.V.

O-GENESIS Graft Delivery System and New Hydrated, Ready-to-Use AlloQuent Structural Allograft Q-PACK Is Launched by Orthofix

O-GENESIS Graft Delivery System (a complete bone graft delivery system) is designed to deliver allograft, autograft or synthetic bone graft to orthopedic surgical sites. The company is also introducing the AlloQuent™ Structural Allograft Q-Pack®

Orthofix Receives FDA 510(k) Clearance of G-Beam Fusion Beaming System

G-Beam Fusion Beaming System was designed primarily for the treatment of Charcot foot, a debilitating condition where the bones in the foot weaken and collapse, the G-Beam devices can be implanted in the medial and lateral columns of the foot to provide alignment, stabilization and fixation.

Publication of Data Further Confirms Effectiveness of the Orthofix Cervical-Stim Device in Improving Fusion Rates

3/5/18: Orthofix International N.V., (NASDAQ:OFIX), a global medical device company focused on musculoskeletal healing products and value-added services, today announced the publication of new data in Bone & Joint Research from a study evaluating the effect of pulsed electromagnetic field treatment for patients who have an increased risk for pseudoarthrosis (failure for the vertebrae to fuse) after anterior cervical discectomy and fusion procedures.

Orthofix Introduces New Brand Identity for Extremity Fixation Pediatric Products

“With a long history of developing innovative and cutting edge extremity fixation technologies, Orthofix has now brought all of our pediatric expertise and products together under the JuniOrtho banner,” said Davide Bianchi, President of the Extremity Fixation...